Ricerca
Disturbo da sintomi somatici e disturbi correlati in età pediatrica
Somatic symptom disorders and related disorders in paediatric age
Camilla Lama1, Raffaella Faggioli2, Federico Marchetti3
1Scuola di Specializzazione in Pediatria, Università di Ferrara
2UOC di Pediatria, Azienda Ospedaliero-Universitaria “Sant’Anna”, Ferrara
3UOC di Pediatria e Neonatologia, Ospedale di Ravenna, AUSL della Romagna
Gennaio 2018 - pagg. 35 -41
Abstract
Background - Somatic symptom disorders (SSD) and related disorders are a frequent
problem in paediatric age that can compromise the quality of life and cause a remarkable
burden for the caregiver.
Objectives - This study analysed the epidemiological data, demographic and clinical features, managing appropriateness and efficacy of an Italian population of paediatric patients who were hospitalised for SSD, with clinical diagnosis based on the DSM-5.
Results - The admissions for SSD were 0.9%. Paediatric SSD patients were more frequently Italian females, with a mean age of 11.7 years. Children/adolescents’ symptoms usually persisted for a long time, with multiple symptoms and school absenteeism. Their clinical history showed multiple health care interventions and non-resolutive therapies, the frequent comorbidity with psychiatric disorders and, rarely, organic diseases. Their hospital management showed many “organic” diagnostic-therapeutic interventions. A specific neuropsychiatric or psychological treatment was started only in 51% cases with a discharge diagnosis ascribable to SSD only in one third of cases.
Conclusions - Paediatricians have to suspect SSD early to limit unnecessary examinations and treatments and to assure a prompt and efficacious neuropsychiatric and/or psychological treatment.
Objectives - This study analysed the epidemiological data, demographic and clinical features, managing appropriateness and efficacy of an Italian population of paediatric patients who were hospitalised for SSD, with clinical diagnosis based on the DSM-5.
Results - The admissions for SSD were 0.9%. Paediatric SSD patients were more frequently Italian females, with a mean age of 11.7 years. Children/adolescents’ symptoms usually persisted for a long time, with multiple symptoms and school absenteeism. Their clinical history showed multiple health care interventions and non-resolutive therapies, the frequent comorbidity with psychiatric disorders and, rarely, organic diseases. Their hospital management showed many “organic” diagnostic-therapeutic interventions. A specific neuropsychiatric or psychological treatment was started only in 51% cases with a discharge diagnosis ascribable to SSD only in one third of cases.
Conclusions - Paediatricians have to suspect SSD early to limit unnecessary examinations and treatments and to assure a prompt and efficacious neuropsychiatric and/or psychological treatment.
Classificazione MeSH
Contenuto riservato
Per leggere l'articolo completo è necessario effettuare il login.
Non sei ancora registrato? Registrati
Bibliografia
1. Malas N, Ortiz-Aguayo R, Giles L, Ibeziako
P. Pediatric somatic symptom disorders. Curr
Psychiatry Rep 2017;19(2):11.
2. Pop-Jordanova N, Zorcec T. Somatoform disorders
- A pediatric experience. Pril (Makedon
Akad Nauk Umet Odd Med Nauki)
2016;37(2-3):55-62.
3. American Psychiatric Association. Diagnostic
and Statistical Manual of Mental Disorders,
5th ed. APA, 2013 (DSM-V).
4. Bujoreanu S, Randall E, Thomson K, Ibeziako
P. Characteristics of medically hospitalized
pediatric patients with somatoform diagnoses.
Hosp Pediatr 2014;4(5):283-90.
5. Guevara JD, Vásquez R. Critical Approach
to Somatomorphic Disorders in Children.
Aproximación crítica a los trastornos somatomorfos
en niños. Rev Colomb Psiquiatr 2012;
41(4):900-9.
6. Rask CU. Functional somatic symptoms in
5-7 year old children: assessment, prevalence
and co-occurrence. Dan Med J 2012;59(11):
B4537.
7. Cottrell DJ. Fifteen-minute consultation:
medically unexplained symptoms. Arch Dis
Child Educ Pract Ed 2016;101(3):114-8.
8. Cerutti R, Spensieri V, Valastro C, Presaghi
F, Canitano R, Guidetti V. A comprehensive
approach to understand somatic symptoms
and their impact on emotional and psychosocial
functioning in children. PLoS One
2017;12(2): e0171867.
9. Ibeziako P, DeMaso DR. Somatic symptom
and related disorders. In: Kliegman RM, Stanton
B, Geme JS, Schor NF, Behrma RE (Editors).
Nelson textbook of Pediatrics 2015. 20th
ed. Philadelphia, PA: Elsevier Health Sciences,
2015. pag. 135-8.
10. Van Geelen SM, Rydelius PA, Hagquist C.
Somatic symptoms and psychological concerns
in a general adolescent population: exploring
the relevance of DSM-V somatic symptom
disorder. J Psychosom Res 2015;79(4):
251-8.
11. Rask CU, Ørnbøl E, Fink PK, Skovgaard
AM. Functional somatic symptoms and consultation
patterns in 5- to 7-year-olds. Pediatrics
2013;132 (2): e459-67.
12. Cozzi G, Minute M, Skabar A, et al. Somatic
symptom disorder was common in
children and adolescents attending an emergency
department complaining of pain. Acta
Paediatr 2017;106(4):586-93.
13. Schulte IE, Petermann F. Somatoform disorders:
30 years of debate about criteria!
What about children and adolescents? J Psychosom
Res 2011;70(3):218-28.
14. Silber TJ. Somatization disorders: diagnosis,
treatment, and prognosis. Pediatr Rev
2011;32 (2):56-63.
15. Andresen JM, Woolfolk RL, Allen LA, et al.
Physical symptoms and psychosocial correlates
of somatization in pediatric primary care.
Clin Pediatr (Phila) 2011;50(10):904-9.
16. Dell ML, Campo JV. Somatoform
disorders in children and adolescents. Psychiatr
Clin North Am 2011;34(3):643-60.
17. Campo JV. Annual research review: functional
somatic symptoms and associated
anxiety and depression-developmental psychopathology
in pediatric practice. J Child
Psychol Psychiatry 2012;53(5):575-92.
18. Allen LA, Woolfolk RL. Cognitive behavioral
therapy for somatoform disorders. Psychiatr
Clin North Am 2010;33(3):579-93.
19. Grover S, Kate N. Somatic symptoms in
consultation-liaison psychiatry. Int Rev Psychiatry
2013;25(1):52-64.
20. Kroenke K. Efficacy of treatment for somatoform
disorders: a review of randomized controlled
trials. Psychosom Med 2007;69(9):881-
8.
21. Kleinstäuber M, Witthöft M, Steffanowski
A, van Marwijk H, Hiller W, Lambert MJ.
Pharmacological interventions for somatoform
disorders in adults. Cochrane Database
Syst Rev 2014;(11):CD010628.
22. Kozlowska K, English M, Savage B. Connecting
body and mind: the first interview
with somatising patients and their families.
Clin Child Psychol Psychiatry 2013;18(2):224-
45.
23. Ibeziako P, Bujoreanu S. Approach to psychosomatic
illness in adolescents. Curr Opin
Pediatr 2011;23(4):384-9.
24. Minute M, Cozzi G, Barbi E. An adolescent
with disabling abdominal pain. BMJ 2016;355:
i6101.
25. Murray AM, Toussaint A, Althaus A, Löwe
B. The challenge of diagnosing non-specific,
functional, and somatoform disorders: a systematic
review of barriers to diagnosis in primary
care. J Psychosom Res 2016;80:1-10.
26. Rief W, Martin A, Rauh E, Zech T, Bender
A. Evaluation of general practitioners’
training: how to manage patients with unexplained
physical symptoms. Psychosomatics
2006;47(4):304-11.
27. Cerchio R, Brondello C, Lenhardt A, et al.
Il malingering come causa di ricovero ospedaliero.
Medico e Bambino pagine elettroniche
2002;5(6).
28. Marchetti F, Lazzerini M, Aliverti R, Ventura
A. Il disturbo somatoforme e fittizio. La
storia di 4 casi. Medico e Bambino 2004;23(6):
377-81.
29. van der Leeuw G, Gerrits MJ, Terluin B,
et al. The association between somatization
and disability in primary care patients. J Psychosom
Res 2015;79(2):117-22.
Corrispondenza: lama.camilla@gmail.com